Theravance Biopharma, Inc.
TBPH
$18.43
-$1.18-6.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 260.85% | 252.63% | 30.89% | -13.74% | -31.82% |
| Total Receivables | 8.44% | 53.29% | 4.70% | 291.67% | -1.24% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -18.42% | -37.61% | -57.99% | -68.65% | -22.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 204.51% | 207.02% | 20.89% | 20.61% | -27.96% |
|
|
|||||
| Total Current Assets | 204.51% | 207.02% | 20.89% | 20.61% | -27.96% |
| Net Property, Plant & Equipment | -14.59% | -17.08% | -21.83% | -21.13% | -20.79% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -87.15% | -86.88% | -21.72% | -22.54% | -1.24% |
| Total Assets | 16.67% | 17.68% | -7.47% | -7.29% | -13.90% |
|
|
|||||
| Total Accounts Payable | 52.20% | 0.06% | 42.82% | 47.11% | -38.60% |
| Total Accrued Expenses | 78.89% | 45.47% | 31.95% | 3.49% | -14.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 160.10% | 158.26% | 165.99% | 173.06% | -56.80% |
| Total Finance Division Other Current Liabilities | -37.23% | 311.34% | -9.82% | -9.82% | 26,941.67% |
| Total Other Current Liabilities | -37.23% | 311.34% | -9.82% | -9.82% | 26,941.67% |
| Total Current Liabilities | 59.62% | 138.09% | 45.43% | 29.55% | -7.62% |
|
|
|||||
| Total Current Liabilities | 59.62% | 138.09% | 45.43% | 29.55% | -7.62% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.42% | -16.21% | -14.81% | -13.55% | -0.81% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.14% | 7.81% | 7.74% | 8.51% | 5.21% |
| Total Liabilities | 7.23% | 19.51% | 6.71% | 5.69% | 1.79% |
|
|
|||||
| Common Stock & APIC | 1.56% | 1.60% | 1.72% | 1.68% | -0.99% |
| Retained Earnings | 3.09% | 1.39% | -6.34% | -6.21% | -5.49% |
| Treasury Stock & Other | -36.00% | 54.55% | -- | 110.77% | 122.22% |
| Total Common Equity | 25.33% | 16.09% | -18.98% | -17.58% | -24.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 25.33% | 16.09% | -18.98% | -17.58% | -24.57% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 25.33% | 16.09% | -18.98% | -17.58% | -24.57% |
|
|
|||||